Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Langsted

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
Current Opinion in Lipidology|April 19, 2020
Lipoprotein(a): is it more, less or equal to LDL as a causal factor for cardiovascular disease and mortality?Anne Langsted, Børge G Nordestgaard
Journal of Lipid Research|September 29, 2016
Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biologyBørge G Nordestgaard, Anne Langsted
Current Atherosclerosis Reports|June 20, 2021
Genetics of Lipoprotein(a): Cardiovascular Disease and Future TherapyAnne Langsted, Børge G Nordestgaard
Pathology|December 8, 2018
Nonfasting versus fasting lipid profile for cardiovascular risk predictionAnne Langsted, Børge G Nordestgaard
Clinical Chemistry|December 30, 2010
Nonfasting lipids, lipoproteins, and apolipoproteins in individuals with and without diabetes: 58 434 individuals from the Copenhagen General Population StudyAnne Langsted, Børge G Nordestgaard
Lancet (London, England)|September 15, 2024
Lipoprotein(a) and cardiovascular diseaseBørge G Nordestgaard, Anne Langsted
Current Atherosclerosis Reports|February 2, 2022
Lipoprotein(a) as Part of the Diagnosis of Clinical Familial HypercholesterolemiaAnne Langsted, Børge G Nordestgaard
Clinical Chemistry|April 22, 2024
Worldwide Increasing Use of Nonfasting Rather Than Fasting Lipid ProfilesAnne Langsted, Børge G Nordestgaard
Current Atherosclerosis Reports|May 22, 2019
Antisense Oligonucleotides Targeting Lipoprotein(a)Anne Langsted, Børge G Nordestgaard
Thrombosis and Haemostasis|January 1, 2019
Smoking is Associated with Increased Risk of Major Bleeding: A Prospective Cohort StudyAnne Langsted, Børge G Nordestgaard
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Current Opinion in Lipidology|April 19, 2020
Lipoprotein(a): is it more, less or equal to LDL as a causal factor for cardiovascular disease and mortality?Anne Langsted, Børge G Nordestgaard
Journal of Lipid Research|September 29, 2016
Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biologyBørge G Nordestgaard, Anne Langsted
Current Atherosclerosis Reports|June 20, 2021
Genetics of Lipoprotein(a): Cardiovascular Disease and Future TherapyAnne Langsted, Børge G Nordestgaard
Pathology|December 8, 2018
Nonfasting versus fasting lipid profile for cardiovascular risk predictionAnne Langsted, Børge G Nordestgaard
Clinical Chemistry|December 30, 2010
Nonfasting lipids, lipoproteins, and apolipoproteins in individuals with and without diabetes: 58 434 individuals from the Copenhagen General Population StudyAnne Langsted, Børge G Nordestgaard
Lancet (London, England)|September 15, 2024
Lipoprotein(a) and cardiovascular diseaseBørge G Nordestgaard, Anne Langsted
Current Atherosclerosis Reports|February 2, 2022
Lipoprotein(a) as Part of the Diagnosis of Clinical Familial HypercholesterolemiaAnne Langsted, Børge G Nordestgaard
Clinical Chemistry|April 22, 2024
Worldwide Increasing Use of Nonfasting Rather Than Fasting Lipid ProfilesAnne Langsted, Børge G Nordestgaard
Current Atherosclerosis Reports|May 22, 2019
Antisense Oligonucleotides Targeting Lipoprotein(a)Anne Langsted, Børge G Nordestgaard
Thrombosis and Haemostasis|January 1, 2019
Smoking is Associated with Increased Risk of Major Bleeding: A Prospective Cohort StudyAnne Langsted, Børge G Nordestgaard
Pageof 8